Cargando…
Genome-Wide Mutational Signature of the Chemotherapeutic Agent Mitomycin C in Caenorhabditis elegans
Cancer therapy largely depends on chemotherapeutic agents that generate DNA lesions. However, our understanding of the nature of the resulting lesions as well as the mutational profiles of these chemotherapeutic agents is limited. Among these lesions, DNA interstrand crosslinks are among the more to...
Autores principales: | Tam, Annie S., Chu, Jeffrey S.C., Rose, Ann M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Genetics Society of America
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704711/ https://www.ncbi.nlm.nih.gov/pubmed/26564951 http://dx.doi.org/10.1534/g3.115.021915 |
Ejemplares similares
-
The Gene scb-1 Underlies Variation in Caenorhabditis elegans Chemotherapeutic Responses
por: Evans, Kathryn S., et al.
Publicado: (2020) -
Genetic and cellular sensitivity of Caenorhabditis elegans to the chemotherapeutic agent cisplatin
por: García-Rodríguez, Francisco Javier, et al.
Publicado: (2018) -
Evaluating the power and limitations of genome-wide association studies in Caenorhabditis elegans
por: Widmayer, Samuel J, et al.
Publicado: (2022) -
Genomic Identification and Functional Characterization of Essential Genes in Caenorhabditis elegans
por: Qin, Zhaozhao, et al.
Publicado: (2018) -
Widespread Genomic Incompatibilities in Caenorhabditis elegans
por: Snoek, L. Basten, et al.
Publicado: (2014)